198 related articles for article (PubMed ID: 33206793)
1. The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening.
Alves G; Chantre M; Delmonico L
An Acad Bras Cienc; 2020; 92(4):e20200919. PubMed ID: 33206793
[TBL] [Abstract][Full Text] [Related]
2. Urine-Based Liquid Biopsy for Nonurological Cancers.
Jain S; Lin SY; Song W; Su YH
Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in circulating nucleic acids in oncology.
Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
5. Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Shen SY; Singhania R; Fehringer G; Chakravarthy A; Roehrl MHA; Chadwick D; Zuzarte PC; Borgida A; Wang TT; Li T; Kis O; Zhao Z; Spreafico A; Medina TDS; Wang Y; Roulois D; Ettayebi I; Chen Z; Chow S; Murphy T; Arruda A; O'Kane GM; Liu J; Mansour M; McPherson JD; O'Brien C; Leighl N; Bedard PL; Fleshner N; Liu G; Minden MD; Gallinger S; Goldenberg A; Pugh TJ; Hoffman MM; Bratman SV; Hung RJ; De Carvalho DD
Nature; 2018 Nov; 563(7732):579-583. PubMed ID: 30429608
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
7. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
8. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
9. Plasma DNA for early cancer detection - opportunities and challenges.
Lam WKJ; Chan KCA
Expert Rev Mol Diagn; 2019 Jan; 19(1):5-7. PubMed ID: 30513010
[No Abstract] [Full Text] [Related]
10. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
11. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free nucleic acids: characteristics and applications.
Pös O; Biró O; Szemes T; Nagy B
Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
[TBL] [Abstract][Full Text] [Related]
13. Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.
Bellassai N; Spoto G
Anal Bioanal Chem; 2016 Oct; 408(26):7255-64. PubMed ID: 27497966
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
Kahlert C
Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
[TBL] [Abstract][Full Text] [Related]
15. Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?
Bailleux C; Lacroix L; Barranger E; Delaloge S
Ann Oncol; 2020 Jun; 31(6):665-667. PubMed ID: 32289381
[No Abstract] [Full Text] [Related]
16. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
18. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy: still early days for early detection.
Watts G
Lancet; 2018 Jun; 391(10140):2593-2594. PubMed ID: 30070213
[No Abstract] [Full Text] [Related]
20. Epigenetic regulation by DNA methylation and miRNA molecules in cancer.
Holubekova V; Mendelova A; Jasek K; Mersakova S; Zubor P; Lasabova Z
Future Oncol; 2017 Oct; 13(25):2217-2222. PubMed ID: 28976205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
